InoKare Therapeutics

InoKare Therapeutics

BiotechChapel HillSeed
inokaretherapeutics.com

Small-molecule inhibitors targeting obesity and metabolic disorders

At a glance

  • HQ: Chapel Hill
  • Sector: Biotech
  • Stage: Seed
  • Last round: Seed

The rest of this record is behind a free account.

Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately, and I read every signup.